Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Storch

Showing results (291-300 of 301) with videos related to

Pageof 31
Sort By:
Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.
The Journal of Clinical Investigation|May 3, 2008
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leakYvonne G Weber, Alexander Storch, Thomas V Wuttke, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.
Nature Communications|January 25, 2018
Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formationMarcel Naumann, Arun Pal, Anand Goswami, et al.
Journal of Parkinson'S Disease|January 24, 2022
Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's DiseaseJennifer Michels, Hendrik van der Wurp, Elke Kalbe, et al.
Journal of Neurology|March 30, 2019
Prognostic factors in ALS: a comparison between Germany and ChinaJohannes Dorst, Lu Chen, Angela Rosenbohm, et al.
Translational Neurodegeneration|April 16, 2019
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptorsFranziska Hopfner, Stefanie H Müller, Dagmar Steppat, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 23, 2026
Alpha-synuclein quantitative seed amplification assay predicts conversion to dementiaStefan Bräuer, Verena Sondermann, Iñaki Schniewind, et al.
Pageof 31

Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.
The Journal of Clinical Investigation|May 3, 2008
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leakYvonne G Weber, Alexander Storch, Thomas V Wuttke, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.
Nature Communications|January 25, 2018
Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formationMarcel Naumann, Arun Pal, Anand Goswami, et al.
Journal of Parkinson'S Disease|January 24, 2022
Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's DiseaseJennifer Michels, Hendrik van der Wurp, Elke Kalbe, et al.
Journal of Neurology|March 30, 2019
Prognostic factors in ALS: a comparison between Germany and ChinaJohannes Dorst, Lu Chen, Angela Rosenbohm, et al.
Translational Neurodegeneration|April 16, 2019
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptorsFranziska Hopfner, Stefanie H Müller, Dagmar Steppat, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 23, 2026
Alpha-synuclein quantitative seed amplification assay predicts conversion to dementiaStefan Bräuer, Verena Sondermann, Iñaki Schniewind, et al.
Pageof 31